The mission of Actualize, Inc. is to bring to society treatments that will surely be needed in ophthalmology in the near future. We will focus on research and development to change ophthalmology by leveraging the strengths of a bio-venture originating from academia, including the ability to discover unmet medical needs, access to cutting-edge research technologies, and a broad network of Key Opinion Leaders (KOLs) worldwide.
Actuarize Corporation aims to develop and launch two types of products as solutions to unmet medical needs for corneal endothelial disorders: 1) eye drops to treat corneal endothelial disorders and 2) cell products for corneal endothelial regenerative medicine.
This website uses cookies for the purpose of operating our services and improving the user experience. For details, please refer to our privacy policy. By clicking on the “Agree” button or continuing to use our website, you will be regarded as having agreed to our use of cookies.
